about
Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunityA systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte traffickingHuman cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy.Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsCCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine modelChemokine receptor requirements for epidermal T-cell trafficking.CD11b+ migratory dendritic cells mediate CD8 T cell cross-priming and cutaneous imprinting after topical immunization.Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.CCR9 Antagonists in the Treatment of Ulcerative Colitis.Sustained activation of cell adhesion is a differentially regulated process in B lymphopoiesisThe role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venulesHumanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsiNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propriaCutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions.alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirusBiased agonism as a mechanism for differential signaling by chemokine receptors.Recombinase activating gene expression in thymic subpopulations. A transitional cell type has lost RAG-2 but not RAG-1.Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants.Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytesCCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes.CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.CC Chemokine Receptor 2 Promotes Recruitment of Myeloid Cells Associated with Insulin Resistance in Non-Alcoholic Fatty Liver Disease.C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic SubjectsCCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS).Complex regulation of CCR9 at multiple discrete stages of T cell developmentCCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptorRole of Rho in chemoattractant-activated leukocyte adhesion through integrinsFlow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytesExpression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individualsChemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migrationCancer associated fibroblast FAK regulates malignant cell metabolismCCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the BloodEfficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation
P50
Q24676033-E75402F9-23C9-4FDF-A83A-A613B61F7931Q28485386-40D2FD1B-30B8-406D-A774-F60AE3CF689EQ33249100-21A40F9F-35E8-4A51-AF0E-277A2D5F6257Q33883515-B898E45B-CDAA-4CF3-8799-DB30BA8F613DQ34052608-05C0C2F1-7F9C-4A6B-9F81-53BACE363031Q34156849-F6AF47CA-A644-4D0F-90AA-E4F3208C5078Q34365089-01A38CD2-F131-4EC2-9938-959CEE279A06Q35071082-0DF79338-B14F-4212-9B31-704DE1A60B0FQ35117831-42914FAD-798E-48DF-97CD-C75B0988042CQ35168188-A8C69C8A-C50A-4056-859B-52FC40033AA6Q36118943-4C794B89-D234-47F5-A5F3-A6DD7B9E85F4Q36370653-15DCAFF6-286F-4C10-BB34-85BC4AEE7D27Q36375848-5C0E295C-A052-4408-8BE2-57DA5EC6FFCDQ36392832-1768F03F-EB47-47E3-84E9-358CDBEE4653Q36930223-0B01DE88-4E0C-47BC-80E0-A1B460A11B5BQ36930246-7CCAC7CC-0C07-42F3-B5BC-443F8A2E31D6Q36955664-1879CACE-82EF-4007-99D6-6C940F1C5AE8Q37272014-57D69A93-F0CB-40AF-9C0F-A3DB13372EFCQ37368610-550910E7-34FF-4FF1-BC51-2DC65AE30782Q38321604-9155051D-6170-414C-BCCF-3BEA54DA8792Q41090098-943D7BFE-0D9A-4A84-8E2C-67589D6CC1F3Q42022690-5AA30E3E-DA37-4B2F-86DA-9934D72E2139Q42965879-EE969F9E-960B-4921-9746-7E30B12B1B91Q43170301-E9CC259B-2D63-43BE-A7C2-450225031CDAQ47709711-F2FE630C-D243-4FCB-BF4C-5F068312DCD7Q48140131-C6B5AC43-3920-4799-9321-AEF9E3848481Q48349923-090B8F60-B6A7-4F96-B2A9-23573258D811Q50116449-C70F18A4-01BE-4A48-90C5-D05E9E64ADC2Q52022548-3EA25F68-BCE7-48EF-A60E-B891BD37F420Q55094015-0CA7000C-A669-4618-B77C-C567DB575B4EQ55228805-CA59081E-7A29-4C7A-871B-12493B663933Q57275455-7613B002-D160-4EA7-966F-E675012F65A4Q61942733-36FCE80D-BE68-4680-9869-7BE295AF9ABBQ70960218-7642FE1E-BFEA-4D1D-B5A5-F9C699CBABE2Q73341423-99BF5192-FE80-41A8-B626-F0FFFEE6EDBEQ73454688-FE82A6BF-CBCE-4497-92F6-4A63E353EB60Q73878054-38A8FB99-D5D7-4CB3-A9EA-44F68259AA6BQ90207575-0AA7AA81-3F19-4119-BD2B-D297C200CF75Q91062044-261F8B32-CC8B-473F-84F0-9E3C02216851Q91339661-E69F3275-88E3-445F-94A5-938FE054B68A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4252-5182
@en
name
James J Campbell
@ast
James J Campbell
@en
James J Campbell
@nl
type
label
James J Campbell
@ast
James J Campbell
@en
James J Campbell
@nl
prefLabel
James J Campbell
@ast
James J Campbell
@en
James J Campbell
@nl
P106
P31
P496
0000-0003-4252-5182